Somalogic Inc 's ability to collect accounts receivable sequentially worsen to 3.84, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Somalogic Inc 's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 95 days, from 80 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 499 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 3158 to 3225.

What is Receivable Turnover Ratio?
What is Somalogic Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SLGC Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	-17.25 %	58.98 %	16.79 %	-0.4 %	70.52 %
Y / Y Revenue Change	-47.14 %	44.71 %	-11.32 %	-18.11 %	108.65 %
Receivable Turnover Ratio (TTM)	3.84	4.54	4.68	5.03	5.24
SLGC's Total Ranking	# 3225	# 3158	# 3167	# 3156	# 3073
Accounts Receivable average collection period days	95	80	78	73	70
Seq. Receivable Change	-4.69 %	-14.99 %	50.45 %	-32.11 %	83.1 %
Seq. Revenue Change	7.72 %	0.44 %	8.23 %	-54.86 %	194.92 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 30
Healthcare Sector	# 500
Overall Market	# 3225

Receivable Turnover Ratio Statistics
High	Average	Low
0.16	0.12	0.05
(Jun 30 2023)		(Jun 30 2022)

SLGC Company Profile • Back to SLGC Efficiency Comparisons • Compare SLGC Receivables Turnover Ratio to its Competitors

Financial Statements
Somalogic Inc 's Accounts Receivable	$ 21 Millions	Visit SLGC's Balance sheet
Somalogic Inc 's Sales TTM	$ 82 Millions	Visit SLGC's Income Statement
Sources of SLGC's Revenues		Visit SLGC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SLGC's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SLGC's Growth Rates	SLGC's Roa	SLGC's Inventory Turnover Ratio	SLGC's Dividend Comparisons
SLGC's Profitability Ratios	SLGC's Roi	SLGC's Asset Turnover Ratio	SLGC's Dividend Growth
SLGC's Valuation Ratios	SLGC's Roe	SLGC's Financial Strength Ratios	SLGC's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Option Care Health Inc	10.83	$ 4,204.399 Millions	$ 388.052 Millions
Intercept Pharmaceuticals inc	10.78	$ 317.684 Millions	$ 29.470 Millions
Avita Medical Inc	10.78	$ 45.403 Millions	$ 4.213 Millions
The Oncology Institute Inc	10.75	$ 490.934 Millions	$ 45.654 Millions
Traws Pharma inc	10.72	$ 0.217 Millions	$ 0.020 Millions
Semler Scientific inc	10.61	$ 66.922 Millions	$ 6.306 Millions
Nrc Health	10.54	$ 148.723 Millions	$ 14.109 Millions
Sunshine Biopharma Inc	10.51	$ 20.352 Millions	$ 1.937 Millions
Catalyst Pharmaceuticals Inc	10.35	$ 348.393 Millions	$ 33.672 Millions
Hookipa Pharma inc	10.32	$ 20.550 Millions	$ 1.991 Millions
Intellia Therapeutics Inc	10.24	$ 51.765 Millions	$ 5.055 Millions
Neptune Wellness Solutions Inc	10.24	$ 43.724 Millions	$ 4.270 Millions
Mannkind Corporation	10.19	$ 176.549 Millions	$ 17.331 Millions
Scienture Holdings Inc	10.04	$ 9.101 Millions	$ 0.907 Millions
Neurometrix Inc	9.95	$ 6.431 Millions	$ 0.646 Millions
United Therapeutics Corporation	9.95	$ 2,204.300 Millions	$ 221.550 Millions
Viemed Healthcare Inc	9.90	$ 169.777 Millions	$ 17.143 Millions
Merus N v	9.76	$ 45.674 Millions	$ 4.682 Millions
Editas Medicine Inc	9.75	$ 24.611 Millions	$ 2.524 Millions
Arbutus Biopharma Corp	9.56	$ 22.241 Millions	$ 2.325 Millions
Quidelortho Corp	9.56	$ 3,121.741 Millions	$ 326.650 Millions
The Pennant Group Inc	9.49	$ 523.602 Millions	$ 55.171 Millions
Femasys Inc	9.49	$ 1.093 Millions	$ 0.115 Millions
Irhythm Holdings Inc	9.40	$ 471.752 Millions	$ 50.163 Millions
Ngm Biopharmaceuticals Inc	9.37	$ 22.433 Millions	$ 2.393 Millions
Biolase Inc	9.36	$ 49.382 Millions	$ 5.276 Millions
Procyon Corporation	9.24	$ 4.684 Millions	$ 0.507 Millions
Tvardi Therapeutics Inc	9.20	$ 21.225 Millions	$ 2.308 Millions
Acorda Therapeutics Inc	9.18	$ 111.118 Millions	$ 12.106 Millions
Harmony Biosciences Holdings inc	9.09	$ 541.622 Millions	$ 59.598 Millions

Date modified: 2026-08-29T17:44:48+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.